Global (United States, European Union and China) Finasteride Tablet

Finasteride Tablet Comprehensive Study by Type (1mg Tablet, 5mg Tablet), Application (Male Pattern Baldness, Benign Prostatic Hyperplasia, Others) Players and Region - Global Market Outlook to 2025

Finasteride Tablet Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Finasteride Tablet Market?

Finasteride is a medication used for the treatment and prevention of Male Pattern Baldness (hair loss in men). It blocks a chemical in the body called 5-alpha-reductase. Finasteride has also been approved for the treatment of Benign Prostatic Hyperplasia (BPH), which is noncancerous enlargement of the prostate gland. Finasteride is not approved for use in women. Obesity & pulmonary diseases are the major causes of the occurrence of BPH. The tablet is available in 2 strengths - 1mg & 5mg. A 1mg dose is suggested for the treatment of Male Pattern hair loss. A 5mg dose is prescribed to treat BPH in men.

The market study is being classified by Type (1mg Tablet and 5mg Tablet), by Application (Male Pattern Baldness, Benign Prostatic Hyperplasia and Others) and major geographies with country level break-up.

Merck & Co. (United States), Sandoz (Germany), Teva Pharmaceutical Industries (Israel), Cipla (India), Marksans Pharma (India), Dr. Reddy Laboratories (India), Accord Pharmaceuticals (United Kingdom), Actavis (United States) and Sivem Pharmaceuticals (Canada) are some of the key players profiled in the study.

Research Analyst at AMA predicts that Indians Players will contribute to the maximum growth of Global Finasteride Tablet market throughout the predicted period.

Segment Analysis
Analyst at AMA have segmented the market study of Global Finasteride Tablet market by Type, Application and Region.

On the basis of geography, the market of Finasteride Tablet has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Increasing Prevalence of BPH in Men


Restraints
  • Harmful Side Effects on Human Body Post Consumption

Opportunities
  • The Rise in Geriatric Population Worldwide
  • Increasing Baldness & Rising Consciousness among Men





Key Target Audience
Finasteride Manufacturer, Distributor & Supplier, Healthcare Industry, Raw Material Supplier, End-User and Others

Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase

Report Objectives / Segmentation Covered

By Type
  • 1mg Tablet
  • 5mg Tablet
By Application
  • Male Pattern Baldness
  • Benign Prostatic Hyperplasia
  • Others
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Prevalence of BPH in Men
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Finasteride Tablet, by Type, Application and Region (value, volume and price ) (2014-2019)
    • 5.1. Introduction
    • 5.2. Global Finasteride Tablet (Value)
      • 5.2.1. Global Finasteride Tablet by: Type (Value)
        • 5.2.1.1. 1mg Tablet
        • 5.2.1.2. 5mg Tablet
      • 5.2.2. Global Finasteride Tablet by: Application (Value)
        • 5.2.2.1. Male Pattern Baldness
        • 5.2.2.2. Benign Prostatic Hyperplasia
        • 5.2.2.3. Others
      • 5.2.3. Global Finasteride Tablet Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global Finasteride Tablet (Volume)
      • 5.3.1. Global Finasteride Tablet by: Type (Volume)
        • 5.3.1.1. 1mg Tablet
        • 5.3.1.2. 5mg Tablet
      • 5.3.2. Global Finasteride Tablet by: Application (Volume)
        • 5.3.2.1. Male Pattern Baldness
        • 5.3.2.2. Benign Prostatic Hyperplasia
        • 5.3.2.3. Others
      • 5.3.3. Global Finasteride Tablet Region
        • 5.3.3.1. South America
          • 5.3.3.1.1. Brazil
          • 5.3.3.1.2. Argentina
          • 5.3.3.1.3. Rest of South America
        • 5.3.3.2. Asia Pacific
          • 5.3.3.2.1. China
          • 5.3.3.2.2. Japan
          • 5.3.3.2.3. India
          • 5.3.3.2.4. South Korea
          • 5.3.3.2.5. Taiwan
          • 5.3.3.2.6. Australia
          • 5.3.3.2.7. Rest of Asia-Pacific
        • 5.3.3.3. Europe
          • 5.3.3.3.1. Germany
          • 5.3.3.3.2. France
          • 5.3.3.3.3. Italy
          • 5.3.3.3.4. United Kingdom
          • 5.3.3.3.5. Netherlands
          • 5.3.3.3.6. Rest of Europe
        • 5.3.3.4. MEA
          • 5.3.3.4.1. Middle East
          • 5.3.3.4.2. Africa
        • 5.3.3.5. North America
          • 5.3.3.5.1. United States
          • 5.3.3.5.2. Canada
          • 5.3.3.5.3. Mexico
    • 5.4. Global Finasteride Tablet (Price)
      • 5.4.1. Global Finasteride Tablet by: Type (Price)
  • 6. Finasteride Tablet: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2019)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Merck & Co. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Sandoz (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Teva Pharmaceutical Industries (Israel)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Cipla (India)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Marksans Pharma (India)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Dr. Reddy Laboratories (India)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Accord Pharmaceuticals (United Kingdom)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Actavis (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Sivem Pharmaceuticals (Canada)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Finasteride Tablet Sale, by Type, Application and Region (value, volume and price ) (2020-2025)
    • 7.1. Introduction
    • 7.2. Global Finasteride Tablet (Value)
      • 7.2.1. Global Finasteride Tablet by: Type (Value)
        • 7.2.1.1. 1mg Tablet
        • 7.2.1.2. 5mg Tablet
      • 7.2.2. Global Finasteride Tablet by: Application (Value)
        • 7.2.2.1. Male Pattern Baldness
        • 7.2.2.2. Benign Prostatic Hyperplasia
        • 7.2.2.3. Others
      • 7.2.3. Global Finasteride Tablet Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global Finasteride Tablet (Volume)
      • 7.3.1. Global Finasteride Tablet by: Type (Volume)
        • 7.3.1.1. 1mg Tablet
        • 7.3.1.2. 5mg Tablet
      • 7.3.2. Global Finasteride Tablet by: Application (Volume)
        • 7.3.2.1. Male Pattern Baldness
        • 7.3.2.2. Benign Prostatic Hyperplasia
        • 7.3.2.3. Others
      • 7.3.3. Global Finasteride Tablet Region
        • 7.3.3.1. South America
          • 7.3.3.1.1. Brazil
          • 7.3.3.1.2. Argentina
          • 7.3.3.1.3. Rest of South America
        • 7.3.3.2. Asia Pacific
          • 7.3.3.2.1. China
          • 7.3.3.2.2. Japan
          • 7.3.3.2.3. India
          • 7.3.3.2.4. South Korea
          • 7.3.3.2.5. Taiwan
          • 7.3.3.2.6. Australia
          • 7.3.3.2.7. Rest of Asia-Pacific
        • 7.3.3.3. Europe
          • 7.3.3.3.1. Germany
          • 7.3.3.3.2. France
          • 7.3.3.3.3. Italy
          • 7.3.3.3.4. United Kingdom
          • 7.3.3.3.5. Netherlands
          • 7.3.3.3.6. Rest of Europe
        • 7.3.3.4. MEA
          • 7.3.3.4.1. Middle East
          • 7.3.3.4.2. Africa
        • 7.3.3.5. North America
          • 7.3.3.5.1. United States
          • 7.3.3.5.2. Canada
          • 7.3.3.5.3. Mexico
    • 7.4. Global Finasteride Tablet (Price)
      • 7.4.1. Global Finasteride Tablet by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Finasteride Tablet: by Type(USD Million)
  • Figure 4. Global Finasteride Tablet: by Type USD Million (2014-2019)
  • Table 2. Finasteride Tablet 1mg Tablet , by Region USD Million (2014-2019)
  • Table 3. Finasteride Tablet 5mg Tablet , by Region USD Million (2014-2019)
  • Table 4. Finasteride Tablet: by Application(USD Million)
  • Figure 5. Global Finasteride Tablet: by Application USD Million (2014-2019)
  • Table 5. Finasteride Tablet Male Pattern Baldness , by Region USD Million (2014-2019)
  • Table 6. Finasteride Tablet Benign Prostatic Hyperplasia , by Region USD Million (2014-2019)
  • Table 7. Finasteride Tablet Others , by Region USD Million (2014-2019)
  • Table 8. South America Finasteride Tablet, by Country USD Million (2014-2019)
  • Figure 6. South America Finasteride Tablet Share (%), by Country
  • Table 9. South America Finasteride Tablet, by Type USD Million (2014-2019)
  • Table 10. South America Finasteride Tablet, by Application USD Million (2014-2019)
  • Table 11. Brazil Finasteride Tablet, by Type USD Million (2014-2019)
  • Table 12. Brazil Finasteride Tablet, by Application USD Million (2014-2019)
  • Table 13. Argentina Finasteride Tablet, by Type USD Million (2014-2019)
  • Table 14. Argentina Finasteride Tablet, by Application USD Million (2014-2019)
  • Table 15. Rest of South America Finasteride Tablet, by Type USD Million (2014-2019)
  • Table 16. Rest of South America Finasteride Tablet, by Application USD Million (2014-2019)
  • Table 17. Asia Pacific Finasteride Tablet, by Country USD Million (2014-2019)
  • Figure 7. Asia Pacific Finasteride Tablet Share (%), by Country
  • Table 18. Asia Pacific Finasteride Tablet, by Type USD Million (2014-2019)
  • Table 19. Asia Pacific Finasteride Tablet, by Application USD Million (2014-2019)
  • Table 20. China Finasteride Tablet, by Type USD Million (2014-2019)
  • Table 21. China Finasteride Tablet, by Application USD Million (2014-2019)
  • Table 22. Japan Finasteride Tablet, by Type USD Million (2014-2019)
  • Table 23. Japan Finasteride Tablet, by Application USD Million (2014-2019)
  • Table 24. India Finasteride Tablet, by Type USD Million (2014-2019)
  • Table 25. India Finasteride Tablet, by Application USD Million (2014-2019)
  • Table 26. South Korea Finasteride Tablet, by Type USD Million (2014-2019)
  • Table 27. South Korea Finasteride Tablet, by Application USD Million (2014-2019)
  • Table 28. Taiwan Finasteride Tablet, by Type USD Million (2014-2019)
  • Table 29. Taiwan Finasteride Tablet, by Application USD Million (2014-2019)
  • Table 30. Australia Finasteride Tablet, by Type USD Million (2014-2019)
  • Table 31. Australia Finasteride Tablet, by Application USD Million (2014-2019)
  • Table 32. Rest of Asia-Pacific Finasteride Tablet, by Type USD Million (2014-2019)
  • Table 33. Rest of Asia-Pacific Finasteride Tablet, by Application USD Million (2014-2019)
  • Table 34. Europe Finasteride Tablet, by Country USD Million (2014-2019)
  • Figure 8. Europe Finasteride Tablet Share (%), by Country
  • Table 35. Europe Finasteride Tablet, by Type USD Million (2014-2019)
  • Table 36. Europe Finasteride Tablet, by Application USD Million (2014-2019)
  • Table 37. Germany Finasteride Tablet, by Type USD Million (2014-2019)
  • Table 38. Germany Finasteride Tablet, by Application USD Million (2014-2019)
  • Table 39. France Finasteride Tablet, by Type USD Million (2014-2019)
  • Table 40. France Finasteride Tablet, by Application USD Million (2014-2019)
  • Table 41. Italy Finasteride Tablet, by Type USD Million (2014-2019)
  • Table 42. Italy Finasteride Tablet, by Application USD Million (2014-2019)
  • Table 43. United Kingdom Finasteride Tablet, by Type USD Million (2014-2019)
  • Table 44. United Kingdom Finasteride Tablet, by Application USD Million (2014-2019)
  • Table 45. Netherlands Finasteride Tablet, by Type USD Million (2014-2019)
  • Table 46. Netherlands Finasteride Tablet, by Application USD Million (2014-2019)
  • Table 47. Rest of Europe Finasteride Tablet, by Type USD Million (2014-2019)
  • Table 48. Rest of Europe Finasteride Tablet, by Application USD Million (2014-2019)
  • Table 49. MEA Finasteride Tablet, by Country USD Million (2014-2019)
  • Figure 9. MEA Finasteride Tablet Share (%), by Country
  • Table 50. MEA Finasteride Tablet, by Type USD Million (2014-2019)
  • Table 51. MEA Finasteride Tablet, by Application USD Million (2014-2019)
  • Table 52. Middle East Finasteride Tablet, by Type USD Million (2014-2019)
  • Table 53. Middle East Finasteride Tablet, by Application USD Million (2014-2019)
  • Table 54. Africa Finasteride Tablet, by Type USD Million (2014-2019)
  • Table 55. Africa Finasteride Tablet, by Application USD Million (2014-2019)
  • Table 56. North America Finasteride Tablet, by Country USD Million (2014-2019)
  • Figure 10. North America Finasteride Tablet Share (%), by Country
  • Table 57. North America Finasteride Tablet, by Type USD Million (2014-2019)
  • Table 58. North America Finasteride Tablet, by Application USD Million (2014-2019)
  • Table 59. United States Finasteride Tablet, by Type USD Million (2014-2019)
  • Table 60. United States Finasteride Tablet, by Application USD Million (2014-2019)
  • Table 61. Canada Finasteride Tablet, by Type USD Million (2014-2019)
  • Table 62. Canada Finasteride Tablet, by Application USD Million (2014-2019)
  • Table 63. Mexico Finasteride Tablet, by Type USD Million (2014-2019)
  • Table 64. Mexico Finasteride Tablet, by Application USD Million (2014-2019)
  • Table 65. Finasteride Tablet Sales: by Type(K Units)
  • Figure 11. Global Finasteride Tablet: by Type K Units (2014-2019)
  • Table 66. Finasteride Tablet Sales 1mg Tablet , by Region K Units (2014-2019)
  • Table 67. Finasteride Tablet Sales 5mg Tablet , by Region K Units (2014-2019)
  • Table 68. Finasteride Tablet Sales: by Application(K Units)
  • Figure 12. Global Finasteride Tablet: by Application K Units (2014-2019)
  • Table 69. Finasteride Tablet Sales Male Pattern Baldness , by Region K Units (2014-2019)
  • Table 70. Finasteride Tablet Sales Benign Prostatic Hyperplasia , by Region K Units (2014-2019)
  • Table 71. Finasteride Tablet Sales Others , by Region K Units (2014-2019)
  • Table 72. South America Finasteride Tablet Sales, by Country K Units (2014-2019)
  • Figure 13. South America Finasteride Tablet Share (%), by Country
  • Table 73. South America Finasteride Tablet Sales, by Type K Units (2014-2019)
  • Table 74. South America Finasteride Tablet Sales, by Application K Units (2014-2019)
  • Table 75. Brazil Finasteride Tablet Sales, by Type K Units (2014-2019)
  • Table 76. Brazil Finasteride Tablet Sales, by Application K Units (2014-2019)
  • Table 77. Argentina Finasteride Tablet Sales, by Type K Units (2014-2019)
  • Table 78. Argentina Finasteride Tablet Sales, by Application K Units (2014-2019)
  • Table 79. Rest of South America Finasteride Tablet Sales, by Type K Units (2014-2019)
  • Table 80. Rest of South America Finasteride Tablet Sales, by Application K Units (2014-2019)
  • Table 81. Asia Pacific Finasteride Tablet Sales, by Country K Units (2014-2019)
  • Figure 14. Asia Pacific Finasteride Tablet Share (%), by Country
  • Table 82. Asia Pacific Finasteride Tablet Sales, by Type K Units (2014-2019)
  • Table 83. Asia Pacific Finasteride Tablet Sales, by Application K Units (2014-2019)
  • Table 84. China Finasteride Tablet Sales, by Type K Units (2014-2019)
  • Table 85. China Finasteride Tablet Sales, by Application K Units (2014-2019)
  • Table 86. Japan Finasteride Tablet Sales, by Type K Units (2014-2019)
  • Table 87. Japan Finasteride Tablet Sales, by Application K Units (2014-2019)
  • Table 88. India Finasteride Tablet Sales, by Type K Units (2014-2019)
  • Table 89. India Finasteride Tablet Sales, by Application K Units (2014-2019)
  • Table 90. South Korea Finasteride Tablet Sales, by Type K Units (2014-2019)
  • Table 91. South Korea Finasteride Tablet Sales, by Application K Units (2014-2019)
  • Table 92. Taiwan Finasteride Tablet Sales, by Type K Units (2014-2019)
  • Table 93. Taiwan Finasteride Tablet Sales, by Application K Units (2014-2019)
  • Table 94. Australia Finasteride Tablet Sales, by Type K Units (2014-2019)
  • Table 95. Australia Finasteride Tablet Sales, by Application K Units (2014-2019)
  • Table 96. Rest of Asia-Pacific Finasteride Tablet Sales, by Type K Units (2014-2019)
  • Table 97. Rest of Asia-Pacific Finasteride Tablet Sales, by Application K Units (2014-2019)
  • Table 98. Europe Finasteride Tablet Sales, by Country K Units (2014-2019)
  • Figure 15. Europe Finasteride Tablet Share (%), by Country
  • Table 99. Europe Finasteride Tablet Sales, by Type K Units (2014-2019)
  • Table 100. Europe Finasteride Tablet Sales, by Application K Units (2014-2019)
  • Table 101. Germany Finasteride Tablet Sales, by Type K Units (2014-2019)
  • Table 102. Germany Finasteride Tablet Sales, by Application K Units (2014-2019)
  • Table 103. France Finasteride Tablet Sales, by Type K Units (2014-2019)
  • Table 104. France Finasteride Tablet Sales, by Application K Units (2014-2019)
  • Table 105. Italy Finasteride Tablet Sales, by Type K Units (2014-2019)
  • Table 106. Italy Finasteride Tablet Sales, by Application K Units (2014-2019)
  • Table 107. United Kingdom Finasteride Tablet Sales, by Type K Units (2014-2019)
  • Table 108. United Kingdom Finasteride Tablet Sales, by Application K Units (2014-2019)
  • Table 109. Netherlands Finasteride Tablet Sales, by Type K Units (2014-2019)
  • Table 110. Netherlands Finasteride Tablet Sales, by Application K Units (2014-2019)
  • Table 111. Rest of Europe Finasteride Tablet Sales, by Type K Units (2014-2019)
  • Table 112. Rest of Europe Finasteride Tablet Sales, by Application K Units (2014-2019)
  • Table 113. MEA Finasteride Tablet Sales, by Country K Units (2014-2019)
  • Figure 16. MEA Finasteride Tablet Share (%), by Country
  • Table 114. MEA Finasteride Tablet Sales, by Type K Units (2014-2019)
  • Table 115. MEA Finasteride Tablet Sales, by Application K Units (2014-2019)
  • Table 116. Middle East Finasteride Tablet Sales, by Type K Units (2014-2019)
  • Table 117. Middle East Finasteride Tablet Sales, by Application K Units (2014-2019)
  • Table 118. Africa Finasteride Tablet Sales, by Type K Units (2014-2019)
  • Table 119. Africa Finasteride Tablet Sales, by Application K Units (2014-2019)
  • Table 120. North America Finasteride Tablet Sales, by Country K Units (2014-2019)
  • Figure 17. North America Finasteride Tablet Share (%), by Country
  • Table 121. North America Finasteride Tablet Sales, by Type K Units (2014-2019)
  • Table 122. North America Finasteride Tablet Sales, by Application K Units (2014-2019)
  • Table 123. United States Finasteride Tablet Sales, by Type K Units (2014-2019)
  • Table 124. United States Finasteride Tablet Sales, by Application K Units (2014-2019)
  • Table 125. Canada Finasteride Tablet Sales, by Type K Units (2014-2019)
  • Table 126. Canada Finasteride Tablet Sales, by Application K Units (2014-2019)
  • Table 127. Mexico Finasteride Tablet Sales, by Type K Units (2014-2019)
  • Table 128. Mexico Finasteride Tablet Sales, by Application K Units (2014-2019)
  • Table 129. Finasteride Tablet: by Type(USD/Units)
  • Figure 18. Global Finasteride Tablet: by Type USD/Units (2014-2019)
  • Figure 19. Global Finasteride Tablet share by Players 2019 (%)
  • Figure 20. Global Finasteride Tablet share by Players (Top 3) 2019(%)
  • Figure 21. Global Finasteride Tablet share by Players (Top 5) 2019(%)
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Finasteride Tablet: by Type(USD Million)
  • Figure 41. Global Finasteride Tablet: by Type USD Million (2020-2025)
  • Table 140. Finasteride Tablet 1mg Tablet , by Region USD Million (2020-2025)
  • Table 141. Finasteride Tablet 5mg Tablet , by Region USD Million (2020-2025)
  • Table 142. Finasteride Tablet: by Application(USD Million)
  • Figure 42. Global Finasteride Tablet: by Application USD Million (2020-2025)
  • Table 143. Finasteride Tablet Male Pattern Baldness , by Region USD Million (2020-2025)
  • Table 144. Finasteride Tablet Benign Prostatic Hyperplasia , by Region USD Million (2020-2025)
  • Table 145. Finasteride Tablet Others , by Region USD Million (2020-2025)
  • Table 146. South America Finasteride Tablet, by Country USD Million (2020-2025)
  • Figure 43. South America Finasteride Tablet Share (%), by Country
  • Table 147. South America Finasteride Tablet, by Type USD Million (2020-2025)
  • Table 148. South America Finasteride Tablet, by Application USD Million (2020-2025)
  • Table 149. Brazil Finasteride Tablet, by Type USD Million (2020-2025)
  • Table 150. Brazil Finasteride Tablet, by Application USD Million (2020-2025)
  • Table 151. Argentina Finasteride Tablet, by Type USD Million (2020-2025)
  • Table 152. Argentina Finasteride Tablet, by Application USD Million (2020-2025)
  • Table 153. Rest of South America Finasteride Tablet, by Type USD Million (2020-2025)
  • Table 154. Rest of South America Finasteride Tablet, by Application USD Million (2020-2025)
  • Table 155. Asia Pacific Finasteride Tablet, by Country USD Million (2020-2025)
  • Figure 44. Asia Pacific Finasteride Tablet Share (%), by Country
  • Table 156. Asia Pacific Finasteride Tablet, by Type USD Million (2020-2025)
  • Table 157. Asia Pacific Finasteride Tablet, by Application USD Million (2020-2025)
  • Table 158. China Finasteride Tablet, by Type USD Million (2020-2025)
  • Table 159. China Finasteride Tablet, by Application USD Million (2020-2025)
  • Table 160. Japan Finasteride Tablet, by Type USD Million (2020-2025)
  • Table 161. Japan Finasteride Tablet, by Application USD Million (2020-2025)
  • Table 162. India Finasteride Tablet, by Type USD Million (2020-2025)
  • Table 163. India Finasteride Tablet, by Application USD Million (2020-2025)
  • Table 164. South Korea Finasteride Tablet, by Type USD Million (2020-2025)
  • Table 165. South Korea Finasteride Tablet, by Application USD Million (2020-2025)
  • Table 166. Taiwan Finasteride Tablet, by Type USD Million (2020-2025)
  • Table 167. Taiwan Finasteride Tablet, by Application USD Million (2020-2025)
  • Table 168. Australia Finasteride Tablet, by Type USD Million (2020-2025)
  • Table 169. Australia Finasteride Tablet, by Application USD Million (2020-2025)
  • Table 170. Rest of Asia-Pacific Finasteride Tablet, by Type USD Million (2020-2025)
  • Table 171. Rest of Asia-Pacific Finasteride Tablet, by Application USD Million (2020-2025)
  • Table 172. Europe Finasteride Tablet, by Country USD Million (2020-2025)
  • Figure 45. Europe Finasteride Tablet Share (%), by Country
  • Table 173. Europe Finasteride Tablet, by Type USD Million (2020-2025)
  • Table 174. Europe Finasteride Tablet, by Application USD Million (2020-2025)
  • Table 175. Germany Finasteride Tablet, by Type USD Million (2020-2025)
  • Table 176. Germany Finasteride Tablet, by Application USD Million (2020-2025)
  • Table 177. France Finasteride Tablet, by Type USD Million (2020-2025)
  • Table 178. France Finasteride Tablet, by Application USD Million (2020-2025)
  • Table 179. Italy Finasteride Tablet, by Type USD Million (2020-2025)
  • Table 180. Italy Finasteride Tablet, by Application USD Million (2020-2025)
  • Table 181. United Kingdom Finasteride Tablet, by Type USD Million (2020-2025)
  • Table 182. United Kingdom Finasteride Tablet, by Application USD Million (2020-2025)
  • Table 183. Netherlands Finasteride Tablet, by Type USD Million (2020-2025)
  • Table 184. Netherlands Finasteride Tablet, by Application USD Million (2020-2025)
  • Table 185. Rest of Europe Finasteride Tablet, by Type USD Million (2020-2025)
  • Table 186. Rest of Europe Finasteride Tablet, by Application USD Million (2020-2025)
  • Table 187. MEA Finasteride Tablet, by Country USD Million (2020-2025)
  • Figure 46. MEA Finasteride Tablet Share (%), by Country
  • Table 188. MEA Finasteride Tablet, by Type USD Million (2020-2025)
  • Table 189. MEA Finasteride Tablet, by Application USD Million (2020-2025)
  • Table 190. Middle East Finasteride Tablet, by Type USD Million (2020-2025)
  • Table 191. Middle East Finasteride Tablet, by Application USD Million (2020-2025)
  • Table 192. Africa Finasteride Tablet, by Type USD Million (2020-2025)
  • Table 193. Africa Finasteride Tablet, by Application USD Million (2020-2025)
  • Table 194. North America Finasteride Tablet, by Country USD Million (2020-2025)
  • Figure 47. North America Finasteride Tablet Share (%), by Country
  • Table 195. North America Finasteride Tablet, by Type USD Million (2020-2025)
  • Table 196. North America Finasteride Tablet, by Application USD Million (2020-2025)
  • Table 197. United States Finasteride Tablet, by Type USD Million (2020-2025)
  • Table 198. United States Finasteride Tablet, by Application USD Million (2020-2025)
  • Table 199. Canada Finasteride Tablet, by Type USD Million (2020-2025)
  • Table 200. Canada Finasteride Tablet, by Application USD Million (2020-2025)
  • Table 201. Mexico Finasteride Tablet, by Type USD Million (2020-2025)
  • Table 202. Mexico Finasteride Tablet, by Application USD Million (2020-2025)
  • Table 203. Finasteride Tablet Sales: by Type(K Units)
  • Figure 48. Global Finasteride Tablet: by Type K Units (2020-2025)
  • Table 204. Finasteride Tablet Sales 1mg Tablet , by Region K Units (2020-2025)
  • Table 205. Finasteride Tablet Sales 5mg Tablet , by Region K Units (2020-2025)
  • Table 206. Finasteride Tablet Sales: by Application(K Units)
  • Figure 49. Global Finasteride Tablet: by Application K Units (2020-2025)
  • Table 207. Finasteride Tablet Sales Male Pattern Baldness , by Region K Units (2020-2025)
  • Table 208. Finasteride Tablet Sales Benign Prostatic Hyperplasia , by Region K Units (2020-2025)
  • Table 209. Finasteride Tablet Sales Others , by Region K Units (2020-2025)
  • Table 210. South America Finasteride Tablet Sales, by Country K Units (2020-2025)
  • Figure 50. South America Finasteride Tablet Share (%), by Country
  • Table 211. South America Finasteride Tablet Sales, by Type K Units (2020-2025)
  • Table 212. South America Finasteride Tablet Sales, by Application K Units (2020-2025)
  • Table 213. Brazil Finasteride Tablet Sales, by Type K Units (2020-2025)
  • Table 214. Brazil Finasteride Tablet Sales, by Application K Units (2020-2025)
  • Table 215. Argentina Finasteride Tablet Sales, by Type K Units (2020-2025)
  • Table 216. Argentina Finasteride Tablet Sales, by Application K Units (2020-2025)
  • Table 217. Rest of South America Finasteride Tablet Sales, by Type K Units (2020-2025)
  • Table 218. Rest of South America Finasteride Tablet Sales, by Application K Units (2020-2025)
  • Table 219. Asia Pacific Finasteride Tablet Sales, by Country K Units (2020-2025)
  • Figure 51. Asia Pacific Finasteride Tablet Share (%), by Country
  • Table 220. Asia Pacific Finasteride Tablet Sales, by Type K Units (2020-2025)
  • Table 221. Asia Pacific Finasteride Tablet Sales, by Application K Units (2020-2025)
  • Table 222. China Finasteride Tablet Sales, by Type K Units (2020-2025)
  • Table 223. China Finasteride Tablet Sales, by Application K Units (2020-2025)
  • Table 224. Japan Finasteride Tablet Sales, by Type K Units (2020-2025)
  • Table 225. Japan Finasteride Tablet Sales, by Application K Units (2020-2025)
  • Table 226. India Finasteride Tablet Sales, by Type K Units (2020-2025)
  • Table 227. India Finasteride Tablet Sales, by Application K Units (2020-2025)
  • Table 228. South Korea Finasteride Tablet Sales, by Type K Units (2020-2025)
  • Table 229. South Korea Finasteride Tablet Sales, by Application K Units (2020-2025)
  • Table 230. Taiwan Finasteride Tablet Sales, by Type K Units (2020-2025)
  • Table 231. Taiwan Finasteride Tablet Sales, by Application K Units (2020-2025)
  • Table 232. Australia Finasteride Tablet Sales, by Type K Units (2020-2025)
  • Table 233. Australia Finasteride Tablet Sales, by Application K Units (2020-2025)
  • Table 234. Rest of Asia-Pacific Finasteride Tablet Sales, by Type K Units (2020-2025)
  • Table 235. Rest of Asia-Pacific Finasteride Tablet Sales, by Application K Units (2020-2025)
  • Table 236. Europe Finasteride Tablet Sales, by Country K Units (2020-2025)
  • Figure 52. Europe Finasteride Tablet Share (%), by Country
  • Table 237. Europe Finasteride Tablet Sales, by Type K Units (2020-2025)
  • Table 238. Europe Finasteride Tablet Sales, by Application K Units (2020-2025)
  • Table 239. Germany Finasteride Tablet Sales, by Type K Units (2020-2025)
  • Table 240. Germany Finasteride Tablet Sales, by Application K Units (2020-2025)
  • Table 241. France Finasteride Tablet Sales, by Type K Units (2020-2025)
  • Table 242. France Finasteride Tablet Sales, by Application K Units (2020-2025)
  • Table 243. Italy Finasteride Tablet Sales, by Type K Units (2020-2025)
  • Table 244. Italy Finasteride Tablet Sales, by Application K Units (2020-2025)
  • Table 245. United Kingdom Finasteride Tablet Sales, by Type K Units (2020-2025)
  • Table 246. United Kingdom Finasteride Tablet Sales, by Application K Units (2020-2025)
  • Table 247. Netherlands Finasteride Tablet Sales, by Type K Units (2020-2025)
  • Table 248. Netherlands Finasteride Tablet Sales, by Application K Units (2020-2025)
  • Table 249. Rest of Europe Finasteride Tablet Sales, by Type K Units (2020-2025)
  • Table 250. Rest of Europe Finasteride Tablet Sales, by Application K Units (2020-2025)
  • Table 251. MEA Finasteride Tablet Sales, by Country K Units (2020-2025)
  • Figure 53. MEA Finasteride Tablet Share (%), by Country
  • Table 252. MEA Finasteride Tablet Sales, by Type K Units (2020-2025)
  • Table 253. MEA Finasteride Tablet Sales, by Application K Units (2020-2025)
  • Table 254. Middle East Finasteride Tablet Sales, by Type K Units (2020-2025)
  • Table 255. Middle East Finasteride Tablet Sales, by Application K Units (2020-2025)
  • Table 256. Africa Finasteride Tablet Sales, by Type K Units (2020-2025)
  • Table 257. Africa Finasteride Tablet Sales, by Application K Units (2020-2025)
  • Table 258. North America Finasteride Tablet Sales, by Country K Units (2020-2025)
  • Figure 54. North America Finasteride Tablet Share (%), by Country
  • Table 259. North America Finasteride Tablet Sales, by Type K Units (2020-2025)
  • Table 260. North America Finasteride Tablet Sales, by Application K Units (2020-2025)
  • Table 261. United States Finasteride Tablet Sales, by Type K Units (2020-2025)
  • Table 262. United States Finasteride Tablet Sales, by Application K Units (2020-2025)
  • Table 263. Canada Finasteride Tablet Sales, by Type K Units (2020-2025)
  • Table 264. Canada Finasteride Tablet Sales, by Application K Units (2020-2025)
  • Table 265. Mexico Finasteride Tablet Sales, by Type K Units (2020-2025)
  • Table 266. Mexico Finasteride Tablet Sales, by Application K Units (2020-2025)
  • Table 267. Finasteride Tablet: by Type(USD/Units)
  • Figure 55. Global Finasteride Tablet: by Type USD/Units (2020-2025)
  • Table 268. Research Programs/Design for This Report
  • Table 269. Key Data Information from Secondary Sources
  • Table 270. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 22. BCG Matrix for key Companies
  • Figure 23. Merck & Co. (United States) Revenue, Net Income and Gross profit
  • Figure 24. Merck & Co. (United States) Revenue: by Geography 2019
  • Figure 25. Sandoz (Germany) Revenue, Net Income and Gross profit
  • Figure 26. Sandoz (Germany) Revenue: by Geography 2019
  • Figure 27. Teva Pharmaceutical Industries (Israel) Revenue, Net Income and Gross profit
  • Figure 28. Teva Pharmaceutical Industries (Israel) Revenue: by Geography 2019
  • Figure 29. Cipla (India) Revenue, Net Income and Gross profit
  • Figure 30. Cipla (India) Revenue: by Geography 2019
  • Figure 31. Marksans Pharma (India) Revenue, Net Income and Gross profit
  • Figure 32. Marksans Pharma (India) Revenue: by Geography 2019
  • Figure 33. Dr. Reddy Laboratories (India) Revenue, Net Income and Gross profit
  • Figure 34. Dr. Reddy Laboratories (India) Revenue: by Geography 2019
  • Figure 35. Accord Pharmaceuticals (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 36. Accord Pharmaceuticals (United Kingdom) Revenue: by Geography 2019
  • Figure 37. Actavis (United States) Revenue, Net Income and Gross profit
  • Figure 38. Actavis (United States) Revenue: by Geography 2019
  • Figure 39. Sivem Pharmaceuticals (Canada) Revenue, Net Income and Gross profit
  • Figure 40. Sivem Pharmaceuticals (Canada) Revenue: by Geography 2019
List of companies from research coverage that are profiled in the study
  • Merck & Co. (United States)
  • Sandoz (Germany)
  • Teva Pharmaceutical Industries (Israel)
  • Cipla (India)
  • Marksans Pharma (India)
  • Dr. Reddy Laboratories (India)
  • Accord Pharmaceuticals (United Kingdom)
  • Actavis (United States)
  • Sivem Pharmaceuticals (Canada)
Select User Access Type

Key Highlights of Report


Aug 2020 237 Pages 62 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global (United States, European Union and China) Finasteride Tablet Quantitative research analysis
Global (United States, European Union and China) Finasteride Tablet Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Know More About Global (United States, European Union and China) Finasteride Tablet Report?

Have a Query? Click Here

Other Related Reports

Dog Vaccine Comprehensive Study by Type (Attenuated Live Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Therapeutic Biologics, Others), Vaccine Consumption (Less than 6 Months...
$ 3650
Eyedrops Comprehensive Study by Type (Artificial tears, Allergy drops, Anti-redness drops), Application (Glaucoma, Eye Infections, Allergies, Dry Eyes, Others), Nature (Natural, Homeopathic, Herbal),...
$ 3650
Isosorbide Mononitrate Comprehensive Study by Type (10 mg Tablet, 20 mg Tablet), Application (Angina Pectoris, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies...
$ 3500
Bisphosphonate Drug Comprehensive Study by Type (Alendronate, Etidronate, Risedronate, Zoledronic Acid), Application (Post-menopausal osteoporosis, Bone Loss caused by Cancer Treatment, Complex Regio...
$ 3650
Aneurysmal Subarachnoid Hemorrhage Drugs Comprehensive Study by Type (Opioid Analgesic, Calcium Channel Blocker, Anticonvulsant, Stool Softener, Osmotic Agent, Other Drugs), End User (Hospitals, Clin...
$ 3500
Opioids Agonist Drugs Comprehensive Study by Type (Morphine, Codeine, Fentanyl, Meperidine), Application (Pain Management, Cough Supression, Diarrhea Suppresion), Receptor Binding (Strong Agonist, Mi...
$ 3350